Talking Points

Episode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI

Informações:

Sinopsis

C. Michael Gibson and Dean Kereiakes discuss the first human use of RUC-4, designed for STEMI point-of-care treatment.